Lingrui Pharmaceutical's major shareholder partially releases pledged shares

Henan Lingrui Group Co., Ltd., a major shareholder of Henan Lingrui Pharmaceutical Co., Ltd., has released 3.38 million pledged shares. This represents 2.77% of Lingrui Group's total holdings and 0.60% of Lingrui Pharmaceutical's total share capital. The release took effect on November 20, 2025.

Following this transaction, Lingrui Group's remaining pledged shares total 28.35 million, accounting for 23.27% of its holdings and 5.00% of the company's total share capital. Lingrui Group currently holds 121.82 million shares in Lingrui Pharmaceutical, representing 21.48% of the company's total share capital. The group has no immediate plans for further pledges of the recently unfrozen shares.

As of the announcement date, Lingrui Group and its concerted parties collectively have 28.35 million shares pledged, which constitutes 22.18% of their combined holdings and 5.00% of Lingrui Pharmaceutical's total share capital. The company emphasized its commitment to continuously monitor pledge situations and fulfill information disclosure obligations.